| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Barriers and facilitators to taking CDK4/6 inhibitors among patients with metastatic breast cancer: a qualitative study
|
Conley, Claire C.
|
|
|
192 |
2 |
p. 385-399
|
artikel
|
| 2 |
Breast cancer treatment patterns by age and time since last pregnancy in the Carolina Breast Cancer Study Phase III
|
Vohra, Sanah N.
|
|
|
192 |
2 |
p. 435-445
|
artikel
|
| 3 |
Comment on: sarcopenia and serum biomarkers of oxidative stress after a 6-month physical activity intervention in women with metastatic breast cancer—results from the ABLE feasibility trial
|
Kirac Utku, Irem
|
|
|
192 |
2 |
p. 463
|
artikel
|
| 4 |
Contribution of cost to treatment nonadherence in the US breast cancer survivors: a population-based analysis
|
Zheng, Caiwei
|
|
|
192 |
2 |
p. 369-373
|
artikel
|
| 5 |
Correction to: Inflammatory breast cancer defined: proposed common diagnostic criteria to guide treatment and research
|
Jagsi, R.
|
|
|
192 |
2 |
p. 245-247
|
artikel
|
| 6 |
Diagnostic and predictive accuracy of anti-mullerian hormone for ovarian function after chemotherapy in premenopausal women with early breast cancer
|
Anderson, Richard A.
|
|
|
192 |
2 |
p. 273-282
|
artikel
|
| 7 |
Factors leading to alpelisib discontinuation in patients with hormone receptor positive, human epidermal growth factor receptor-2 negative breast cancer
|
Cheung, Yee-Ming M.
|
|
|
192 |
2 |
p. 303-311
|
artikel
|
| 8 |
Feasibility of personalized screening and prevention recommendations in the general population through breast cancer risk assessment: results from a dedicated risk clinic
|
Saghatchian, Mahasti
|
|
|
192 |
2 |
p. 375-383
|
artikel
|
| 9 |
Hypofractionated proton therapy in breast cancer: where are we? A critical review of the literature
|
Alterio, Daniela
|
|
|
192 |
2 |
p. 249-263
|
artikel
|
| 10 |
Impact of body mass index on the efficacy of aromatase inhibitors in patients with metastatic breast cancer
|
Patel, Rima
|
|
|
192 |
2 |
p. 313-319
|
artikel
|
| 11 |
IMPARTER, Phase 1 of an intervention to improve patients’ understanding of gene expression profiling tests in breast cancer
|
Fallowfield, L. J.
|
|
|
192 |
2 |
p. 265-271
|
artikel
|
| 12 |
Implication of body mass index (BMI) on the biological and clinical effects of endocrine therapy plus abemaciclib as neoadjuvant therapy for early breast cancer patients
|
Franzoi, Maria Alice
|
|
|
192 |
2 |
p. 457-462
|
artikel
|
| 13 |
Inflammatory breast cancer defined: proposed common diagnostic criteria to guide treatment and research
|
Jagsi, R.
|
|
|
192 |
2 |
p. 235-243
|
artikel
|
| 14 |
Insulin resistance and the development of breast cancer in premenopausal women: the Kangbuk Samsung Health Study
|
Lee, Jeesun
|
|
|
192 |
2 |
p. 401-409
|
artikel
|
| 15 |
Ki-67 and breast cancer prognosis: does it matter if Ki-67 level is examined using preoperative biopsy or postoperative specimen?
|
Choi, Soon Bo
|
|
|
192 |
2 |
p. 343-352
|
artikel
|
| 16 |
Lack of racial differences in clinical outcomes of breast cancer patients receiving neoadjuvant chemotherapy: a single academic center study
|
Sarma, Maithreyi
|
|
|
192 |
2 |
p. 411-421
|
artikel
|
| 17 |
Preventing taxane-related peripheral neuropathy, pain and nail toxicity: a prospective self-controlled trial comparing hilotherapy with frozen gloves in early breast cancer
|
Coolbrandt, Annemarie
|
|
|
192 |
2 |
p. 293-301
|
artikel
|
| 18 |
Racial differences in breast cancer outcomes by hepatocyte growth factor pathway expression
|
Jones, Gieira S.
|
|
|
192 |
2 |
p. 447-455
|
artikel
|
| 19 |
Somatic loss of the remaining allele occurs approximately in half of CHEK2-driven breast cancers and is accompanied by a border-line increase of chromosomal instability
|
Iyevleva, Aglaya G.
|
|
|
192 |
2 |
p. 283-291
|
artikel
|
| 20 |
The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry
|
Meegdes, Marissa
|
|
|
192 |
2 |
p. 331-342
|
artikel
|
| 21 |
The progesterone-receptor modulator, ulipristal acetate, drastically lowers breast cell proliferation
|
Westhoff, Carolyn L.
|
|
|
192 |
2 |
p. 321-329
|
artikel
|
| 22 |
The relationship between sleep and weight change among women diagnosed with breast cancer participating in the Women’s Health Initiative
|
Donzella, Sidney M.
|
|
|
192 |
2 |
p. 423-433
|
artikel
|
| 23 |
Tumor-promoting mechanisms of macrophage-derived extracellular vesicles-enclosed microRNA-660 in breast cancer progression
|
Li, Changchun
|
|
|
192 |
2 |
p. 353-368
|
artikel
|
Tijdschrift beschrijving